WuXi Biologics CEO: Vaccine CDMO is the next area of growth

Dr Chris Chen launches WuXi Vaccines, announces new facility and a 20-year manufacturing contract worth US$3 billion

picture of

Breaking News

EnteroBiotix secures MHRA license for clinical trial manufacturing

The Scottish microbiome specialists is also working on creating a common European regulatory framework for microbiome ...

Concept Life Sciences opens new niche API facility

UK-based company now offers services from development to cGMP-compliant production

Iveric Bio chooses Catalent for AAV vector manufacturing

Vectors are for preclinical uses in retinal disease gene therapy candidates

Small molecule CDMOs reacting to changing market demands

The pharmaceutical industry continues to evolve in two interesting ways: first, the development pipeline sees a variety ...

NanoComposix enters drug CMO market

The nanomaterial producer has expanded capabilities to include drug manufacture as it receives drug manufacturing ...

Dassault Systemes acquires Medidata Solutions for $5.8bn

French software company makes a strategic acquisition as 13 of the top 15 drugs sold in 2018 were powered by ...

The Manufacturing Chemist outsourcing roundtable: part II

Having talked about upcoming trends, potential growth and in-demand services in Part I, I open the second session by ...

AptarGroup makes double acquisition worth $50m

Nanopharm and Gateway Analytical operations are complementary to the group’s pharma service offerings

Lonza expands HPAPI production capacity in Visp

This expansion in Switzerland will add two 4 m3-scale, multi-purpose production lines for HPAPI manufacturing

The Manufacturing Chemist outsourcing roundtable: part I

Discussing the upcoming and ongoing trends in the contract pharmaceutical sector, Dr Kevin Robinson recently caught up ...

Broad stripes, bright stars and a thriving pharmaceutical industry: part I

According to one of Stephen Sondheim’s most well-known lyrics, “I like to be in America! OK by me in America!” ...

CDMO market trends and dynamics

The rise of the embedded model

Almac Group launches Almac Adapt, a new patient-centric supply solution

Innovative just-in-time manufacturing (JTM) enables sponsors full late stage customisation of their clinical trial ...

Tergus Pharma moves into CDMO market

New 100,000 sqft facility will expand topical manufacturing capabilities by 400% to support the drive into this new ...